Patents by Inventor Regent Laporte

Regent Laporte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of peptidic vasopression receptor agonists
    Patent number: 9050286
    Abstract: The present invention relates to the use of novel compounds for the manufacture of a medicament for treatment of inter alia conditions associated with critical care as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds utilized are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: August 8, 2008
    Date of Patent: June 9, 2015
    Assignee: Ferring B.V.
    Inventors: Regent Laporte, Pierre J-M Riviere
  • Peptidic vasopressin receptor agonists
    Patent number: 8778881
    Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: July 15, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent LaPorte, Robert Felix Galyean, Pierre J.M. Riviere
  • Peptidic Vasopressin Receptor Agonists
    Publication number: 20120196808
    Abstract: The present application relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: March 1, 2012
    Publication date: August 2, 2012
    Applicant: FERRING B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent LaPorte, Robert Felix Galyean, Pierre Riviere
  • Use of peptidic vasopressin receptor agonists
    Patent number: 8222202
    Abstract: The present invention relates to the use of novel compounds for the manufacture of a medicament for treatment of, inter alia, conditions associated with critical care sepsis, septic shock, hepatorenal syndrome type I, hypertension induced by endstage venal disease, severe burns, thermal injury as well as to a method for treatment of the conditions by administering the compounds. The compounds used are represented by the general formula (1), as further defined in the specification.
    Type: Grant
    Filed: February 12, 2007
    Date of Patent: July 17, 2012
    Assignee: Ferring B.V.
    Inventors: Regent Laporte, Pierre J. M. Riviere
  • Peptidic vasopressin receptor agonists
    Patent number: 8148319
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: April 3, 2012
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent Laporte, Robert Felix Galyean, Pierre Riviere
  • USE OF PEPTIDIC VASOPRESSION RECEPTOR AGONISTS
    Publication number: 20110237494
    Abstract: The present invention relates to the use of novel compounds for the manufacture of a medicament for treatment of inter alia conditions associated with critical care as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds utilised are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: August 8, 2008
    Publication date: September 29, 2011
    Inventors: Regent Laporte, Pierre J-M Riviere
  • USE OF V2 RECEPTOR ANTAGONISTS IN COMBINATION WITH VASO PRESSINERGIC AGNOSTS
    Publication number: 20100311642
    Abstract: The combination of vasopressin V2 receptor antagonists and vasopressin receptor agonists (selective or non-selective) is described, including pharmaceutical compositions, including kits, for administering, and methods and uses of such a combination, e.g. for treatment of critical care diseases and conditions requiring control of arterial blood pressure or for treatment of hypotension.
    Type: Application
    Filed: September 25, 2008
    Publication date: December 9, 2010
    Applicant: Ferring B.V.
    Inventors: Pierre J-m.Riviere, Sudar Alagarsamy, Claudio Daniel Schteingart, Regent Laporte
  • Use of Peptidic Vasopressin Receptor Agonists
    Publication number: 20090305959
    Abstract: The present invention relates to the use of novel compounds for the manufacture of a medicament for treatment of, inter alia, conditions associated with critical care as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds utilised are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: February 12, 2007
    Publication date: December 10, 2009
    Inventors: Regent Laporte, Pierre J-M Rivirèe
  • Peptidic vasopressin receptor agonists
    Publication number: 20090054309
    Abstract: The present invention relates to novel compounds, pharmaceutical compositions comprising the same, use of said compounds for the manufacture of a medicament for treatment of inter alia shock conditions as well as to a method for treatment of said conditions, wherein said compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification.
    Type: Application
    Filed: August 3, 2005
    Publication date: February 26, 2009
    Applicant: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Schteingart, Regent Laporte, Robert Felix Galyean, Pierre Riviere